Danaparoid : used, mechanism of action, pharmacodynamic

Danaparoid : used, mechanism of action, pharmacodynamic | webmedi.blogspot.com

Danaparoid

Brand name:- Orgaran.

Danaparoid is a preparation containing mainly heparan sulfate which is a heparin - like substance found in many tissues, having less potent anticoagulant action than heparin. Danaparoid is obtained from pig gut mucosa , and is used in cases with heparin induced thrombocytopenia.

Pharmacodynamic:-

Danaparoid contains a mixture of heparan sulfate, dermatan sulfate and chondroitin sulfate in amounts of approximately 84%, 12% and 4%, respectively . Danaparoid is as an antithrombotic agent that prevents the formation of fibrin in the coagulation pathway. It has a high antifactor Xa to antifactor IIa (thrombin) activity that primarily works via antithrombin III-mediated inhibition of factor Xa . The ratio of antifactor Xa to antifactor II activity is ≥ 20:1 . Danaparoid has a minor effect on platelet function and aggregation Label. In a worldwide compassionate-use programme involving a total of 667 patients with heparin-induced thrombocytopenia (HIT), treatment with danaparoid resulted in 93% of successful outcomes in resolving HIT .

In healthy volunteers, danaparoid caused significantly less prolongation o f the activated partial thromboplastin time (APTT) and was associated with a significantly lower thrombin time than unfractionated heparin (UFH) and low molecular weight heparins (LMWHs) . Danaparoid displays lower lipolytic activity than UFH in vitro and in healthy individuals, leading to lower plasma levels of free fatty acids . Danaparoid has been associated with the cross-reactivity with pathogenic heparin-induced platelet-factor (PF4) antibodies, which occurs in about 10 % or more by in vitro testing .The clinical relevance of this effect is not fully understood .

Mechanism of action:-

In the coagulation cascade leading to clot formation, factor X and factor II requires activation to promote subsequent conversion of fibrinogen to fibrin. The mechanism of action of danaparoid resulting in anticoagulant and antithrombic effects involves a complex interaction between 2 components, factor IIa and in particular, factor Xa . Via binding to antithrombin and inducing a conformational change 4, danaparoid enhances and catalyzes the the binding of factor Xa to antithrombin, which induces antithrombin-mediated inactivation of factor Xa. This leads to inhibition of thrombin generation and subsequently, thrombus formation . Danaparoid also weakly enhances antithrombin III and heparin cofactor II inactivation of factor IIa . There is evidence that danaparoid also suppresses the activation of factor IX which, in conjunction with simultaneous inhibition of factor X, may lead to antithrombic effects .

Used:-

Danaparoid is used to prevent deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs. These blood clots can travel to the lungs and can become lodged in the blood vessels of the lungs, causing a condition called pulmonary embolism. Danaparoid is used for several days after hip replacement surgery, while you are unable to walk. It is during this time that blood clots are most likely to form.

Side effects:-

Bleeding, low platelet & Possibly Asthma exacerbations, due to allergies to sulfites contained within the medicine (no case has been reported to date).

Doses:- AS DIRECTED BY YOUR DOCTOR.

BASILIXIMAB Uses, Side Effects, and More

BASILIXIMAB BRAND NAME:- Simulect BASILIXIMAB is another anti CD - 25 antibody with higher affinity for the IL-2 receptor, but shorter plasma t½ (1 week) . is a monoclonal antibody used to prevent rejection in kidney transplants. It is a chimeric mouse-human monoclonal antibody to the α chain (CD25) of the IL-2 receptor of T cells. It is used in combination with other medicines used to prevent organ rejection. PHARMACODYNAMIC:- Basiliximab functions as an IL-2 receptor antagonist. Specifically it inhibits IL-2-mediated activation of lymphocytes, a critical pathway in the cellular immune response involved in allograft rejection. MECHANISM OF ACTION:- Basiliximab competes with IL-2 to bind to the alpha chain subunit of the IL2 receptor on the surface of the activated T lymphocytes and thus prevents the receptor from signaling. This prevents T cells from replicating and also from activating B cells, which are responsible for the production of antibodies, which would bind to the trans

Cefpodoxime proxetil Uses, Side Effects, and More

Cefpodoxime proxetil Brand name:- cefoprox ,cepodem,DOXCEF 100,200mg cap. Cefpodoxime Proxetil is an antibiotic. It kills the bacteria by preventing them from forming the bacterial protective covering (cell wall) which is needed for them to survive. Pharmacodynamic:- Cefpodoxime is shown to be effective against most Gram positive and Gram negative bacteria, except Pseudomonas aeruginosa, Enterococcus, and Bacteroides fragilis. Mechanism of action:- Cefpodoxime is active against a wide spectrum of Gram-positive and Gram-negative bacteria. Cefpodoxime is stable in the presence of beta-lactamase enzymes. As a result, many organisms resistant to penicillins and cephalosporins, due to their production of beta-lactamase, may be susceptible to cefpodoxime. Cefpodoxime is inactivated by certain extended spectrum beta-lactamases. The bactericidal activity of cefpodoxime results from its inhibition of cell wall synthesis. The active metabolite of cefpodoxime binds preferentially to penicilli

Know details about AMIKACIN DRUG ?

AMIKACIN BRAND NAME:- AMICIN , MIKACIN, MIKAJECT 100mg ,250mg,500mg in 2ml inj. AMIKACIN it is a semisynthetic derivative of KANAMYCIN to which it resembles in pharmacokinetics,dose and toxicity. The outstanding feature of AMIKACIN is its resistance to bacterial aminoglycoside inactivating enzymes. Thus, it has to the widest spectrum of activity, including many organisms resistant to other aminoglycoside. However, relatively higher doses are needed for pseudomonas, Proteus and Staph. Infections. The range of condition in which AMIKACIN can be used is the same as for gentamicin. It is recommended as a reserve drug for empirical treatment of hospital acquired gram-negative bacillary infections where gentamicin/tobramycin resistance is High. It is effective in tuberculosis,but used only for multidrug resistant infection.More hearing loss than vestibular disturbances occurs in toxicity. Pharmacodynamic:- Amikacin is an aminoglycoside antibiotic. Aminoglycosides bind to the bacteria, c

webmedi.blogspot.com

Search This Blog